Viramune (Nevirapine)
| Brand Name: |
Viramune |
| Generic Name: |
Nevirapine, NVP |
| Adult Single Dose: |
One 200-mg tablet (once a day) for
14 days then one 200-mg tablet (twice a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NNRTI |
The Basics
News
- Changes in Viramune XR Tablets for Kids (January/February 2013)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Approval of Generic ARVs: Nevirapine and Combivir Now Off-Patent in the U.S. (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves Generic Formulations of Lamivudine and Zidovudine Tablets and Nevirapine Tablets and Oral Suspension (May 25, 2012)
From U.S. Food and Drug Administration
 Generic Nevirapine Now Available -- But the Big One Is Next Year (May 25, 2012)
From Journal Watch
On TheBodyPRO.com
- Nevirapine Prolonged Release Once-Daily Formulation Available in the UK (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves Extended-Release Version of HIV Drug (April 6, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approves Nevirapine XR (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Announces Approval of Once-Daily Form of Viramune (Nevirapine) (March 28, 2011)
From U.S. Food and Drug Administration
- Switching to Viramune Is Possible at Higher CD4s (February 1, 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- New Assistance Program Helps HIVers Pay for Viramune (October 7, 2009)
From TheBody.com
VIEW ALL ARTICLES
|
|
Advertisement
|
Email
Glossary
